跳至主要内容
临床试验/IRCT20080831001141N43
IRCT20080831001141N43招募中1 期

Safety and feasibility study of intra-ovarian injection of bone marrow mesenchymal stromal cells-derived extracellular vesicles in idiopathic premature ovarian failure patients: Clinical trial phase I

otus Royan Charitable Fundation0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 38 years(—)
性别
Female

入选标准

  • Women between 20-38 years old
  • Baseline serum level of follicle stimulating hormone (FSH) higher or equal to 25 IU/l at least twice with an interval of 3 or 4 months
  • At least one year has passed since secondary amenorrhea and premature ovarian failure (POF) diagnosis
  • Normal karyotype and fragile X messenger ribonucleoprotein 1 (FMR1) gene

排除标准

  • Primary amenorrhea
  • Congenital anomaly of the ovary
  • Thyroid disease
  • Immune system diseases such as lupus and...
  • Previous and/or family history of ovarian tumor
  • Previous and/or family history of suffering from major diseases in the past and present such as cancer
  • Positive serological evidence regarding previous or current hepatitis B and C, Human T-lymphotropic virus 1, Human immunodeficiency virus (HIV), Syphilis
  • Disturbance in the normal range of laboratory tests as levels of Hemoglobin Subunit Alpha 1 (HbA1), Alanine transaminase (ALT), The aspartate aminotransferase (AST), the number of white blood cells (WBCs), The creatinine (Cr), International normalised ratio (INR) , Platelets (Plt), Hematocrit (Hct) tests.
  • History of specific systemic disease (rheumatology, endocrine, cardiovascular, etc.)
  • Severe endometriosis (stage III and IV)
  • Small and non-injectable ovaries
  • Lack of patient satisfaction
  • The patient's unwillingness to continue participating in the plan

研究者

发起方
otus Royan Charitable Fundation

相似试验

Investigating the effect of intraovarian injection... | 临床试验